成分分析

制霉素中未知成分的结构鉴定及UHPLC法含量测定*

展开
  • 1.中国医学科学院北京协和医学院医药生物技术研究所, 北京 100050;
    2.浙江震元制药有限公司浙江震元制药研究院, 绍兴 312071
第一作者 Tel: (010) 67019851; E-mail: zpsunshengnan@163.com
**山广志 Tel: (010) 63021345; E-mail: shanguangzhi@imb.pumc.edu.cn
解云英 Tel: (010) 63165276; E-mail: xieyy@imb.pumc.edu.cn

收稿日期: 2020-03-15

  网络出版日期: 2024-07-12

基金资助

*十三五新药创制重大专项(2017ZX09101001)

Identification and determination of unknown component in nysfungin by UHPLC*

Expand
  • 1. Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical Colege, Beijing 100050, China;
    2. Zhejiang Zhenyuan Pharmaceutical Research Institute, Zhejiang Zhenyuan Pharmaceutical Co., Ltd., Shaoxing 312071, China

Received date: 2020-03-15

  Online published: 2024-07-12

摘要

目的:鉴定制霉素中未知成分(RT6)的结构, 并建立该成分的UHPLC 含量测定方法。方法:从原料药中分离纯化未知成分, 利用核磁共振波谱和高分辨质谱对未知成分(RT6)进行结构鉴定和解析。采用Thermo Hypersil GOLD C18(100 mm×2.1 mm, 1.9 μm)色谱柱, 甲醇-乙腈-28 mmol·L-1 醋酸铵溶液(0.8%乙酸)为流动相, 梯度洗脱, 流速0.2 mL·min-1, 柱温30 ℃, 检测波长305 nm。结果:经NMR 和HRMS 鉴定, 制霉素中未知成分为白诺氏菌素。在建立的色谱条件下, 该成分与其他成分分离良好, 质量浓度在1.70~6.80 μg·mL-1(r=0.999 9)范围内与峰面积呈良好线性关系, 低、中、高3 个水平下平均回收率分别为103.6%、99.4% 和100.1%, RSD 分别为0.33%、1.6% 和0.90%。3 批供成品中白诺氏菌素的含量检测结果分别为3.97%、3.41%、3.72%。结论:制霉素原料中存在的未知成分为白诺氏菌素。经方法学验证, 建立的UHPLC 方法可用于制霉素原料药中白诺氏菌素的测定与控制。

本文引用格式

孙胜男, 冷霄云, 李怡然, 孙忠浩, 李晓茜, 孟祥燕, 解云英, 山广志 . 制霉素中未知成分的结构鉴定及UHPLC法含量测定*[J]. 药物分析杂志, 2021 , 41(8) : 1375 -1380 . DOI: 10.16155/j.0254-1793.2021.08.11

Abstract

Objective:To identify the structure of unknown component (RT6) in nysfungin and establish UHPLC method for content determination. Methods:The unknown component (RT6) was identified by NMR and HRMS. And the determination was performed by Thermo Hypersil GOLD C18 (100 mm×2.1 mm, 1.9 μm) column, with the mobile phase consisted of methanol, acetonitrile and 28 mmol·L-1 ammonium acetate (0.8% acetic acid) by gradient elution. The flow rate was 0.2 mL·min-1, the column temperature was 30 ℃, and the detection wavelength was 305 nm. Results:The unknown component (RT6) in nysfungin was identified as albonoursin. RT6 was well separated from other component and showed a good linearity in the concentration range of 1.70-6.80 μg·mL-1 (r=0.999 9). The average recoveries at low, medium and high levels were 103.6%, 99.4% and 100.1%, respectively, and the RSDs were 0.33%, 1.6% and 0.90%, respectively. The result showed that the contents of albonoursin in three batches of samples were 3.97%, 3.41% and 3.72%. Conclusion:The unknown component in nysfungin is albonoursin. The established UHPLC method can be used for the determination and control of albonoursin in nysfungin.

参考文献

[1] 包琴珠,襲炳永,蔡润生.制霉素A-94 的研究 Ⅱ.制霉素A-94 的制备和性质研究[J].科学通报,1959,10(24):825
BAO QZ,XI BY,CAI RS.Studies on nystatin A-94 Ⅱ.Preparation and properties of nystatin A-94[J].Chin Sci Bull,1959,10(24): 825
[2] 蔡润生,包琴珠,吴淑云,等.从中国南方土壤分离的三种放线菌产生的多烯类抗菌素[J].药学学报,1960,8(1):47
CAI RS,BAO QZ,WU SY,et al.Three types of polyene antibiotics produced by actinomycetes isolated from the soils of Southern China[J].Acta Pharm Sin,1960,8(1):47
[3] 姚志文,李光辉.抗真菌药新剂型–制霉素脂质体[J].中国抗感染化疗杂志,2005,5(4):250
YAO ZW,LI GH.New formulation of antifungal agent-liposomal nystatin(Nystatin LF)[J].Chin J Infect Chemother,2005,5(4): 250
[4] 王绍文,任美瑞,朱凤娟,等.国产制霉菌素主要组分的抗真菌活性[J].中国抗生素杂志,1987,(2):13
WANG SW,REN MR,ZHU FJ,et al.Antifungal activities of the major compositions of nystatin of China[J].Chin J Antibiot,1987, (2):13
[5] BRESCANSIN EG,PORTILHO M,PESSINE FBT.Physical and chemical analysis of commercial nystatin[J].Acta Sci Health Sci, 2013,35(2):215
[6] THOMAS AH,PHARM B,NEWLAND P,et al.Identification and determination of the qualitative composition of nystatin using thin-layer chromatography and high-performance liquid chromatography[J].J Chromatog A,1981,216:367
[7] THOMAS AH,NEWLAND P,SHARMA NR.The heterogeneous composition of pharmaceutical-grade nystatin[J].Analyst,1982, 107(1277):849
[8] 汪素岩,王健,孟铮.制霉素中制霉素 A1、A3 和多真菌素 B 含量比例的研究[J].中国药事,1996,10(1):41
WANG SY,WANG J,MENG Z.Study on constitute proportions of nystatin A1,A3 and polyfungin B[J].Chin Pharm Aff,1996,10(1):41
[9] 周桂云,陈平,田智慧,等.制霉菌素片质量控制研究[J].科技资讯,2012(6):61
ZHOU GY,CHEN P,TIAN ZH,et al.Study on quality control of nystatin tablets[J].Sci Technol Inf,2012(6):61
[10] CHONG CN,RICKARDS RW.Macrolide antibiotic studies.ⅩⅥ.The structure of nystatin[J].Tetrahedron Lett,1970,11(59):5145
[11] RAMESH C,PANDEY,KENNETH L,et al.Polyene antibiotics. Ⅶ . Carbon-13 nuclear magnetic resonance evidence for cyclic hemiketals in the polyene antibiotics amphotericin B, nystatin A1, tetrin A, tetrin B, lucensomycin, and pimaricin 1,2[J].J Antibiot,1976,29(10):1035
[12] 凌大奎,陈苏,王绍文,等.国产制霉菌素中两个主成分的结构鉴别[J].药学学报,1986,21(6):454
LING DK,CHEN S,WANG SW,et al.Identification of two major components in Chinese nystatin[J].Acta Pharm Sin,1986,21(6):454
[13] SHIN C,CHIGIRA Y,MASAKI M,et al.Total synthesis of albonoursin[J].Tetrahedron Lett,1967,8(46) :4601
[14] TRAKHTENBERG DM,RODINOVSKAIA EI,GORDINA ZV,et al.Studies on properties and chemical purification of nystatin[J]. Antibiotiki,1960,5:9
[15] FUKUSHIMA K,YAZAWA K,ARAI T.Biological activities of albonosin[J].J Antibiot,1973,26(3):175
[16] LOKSHIN GB,KHOKHLOV AS,SHEINKER YN,et al.A chemical and spectrosgopic study of albonoursin[J].Chem Nat Compd, 1965,1(6):310
[17] WS1-XG-056-2011 制霉素片[S].2011
WS1-XG-056-2011 Nysfungin Tablets[S].2011
文章导航

/